Mesa Laboratories (MLAB) AI Stock Analysis

• Market Cap: $512.87M
• Dividend Yield: 0.79%
• Average Volume (3M): 148.03K
• Price to Earnings (P/E): 29.9
• Beta (1Y): 1.36
• Revenue Growth: 7.39%
• EPS Growth: 99.34%
• Country: US
• Employees: 736
• Sector: Technology
• Sector Strength: 88
• Industry: Hardware, Equipment & Parts
• EPS (TTM): 3.07
• Shares Outstanding: 5,524,813
• 10 Day Avg. Volume: 101,777
• 30 Day Avg. Volume: 148,032
• PEG Ratio: 3.29
• Price to Book (P/B): 4.03
• Price to Sales (P/S): 2.67
• P/FCF Ratio: 15.23
• Enterprise Value/Market Cap: 1.15
• Enterprise Value/Revenue: 2.37
• Enterprise Value/Gross Profit: 3.91
• Enterprise Value/Ebitda: 13.25
• 1Y Price Target: $104.50
• Price Target Upside: 12.57% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2
• EPS Forecast (FY): 6.34
• Revenue Forecast (FY): $263.03M

• Rating: 58 Neutral
• Price Target: $98.00 ▲(5.57% Upside)
• Action: Reiterated Date: 03/12/26
• Date: Action: Reiterated 03/12/26

The score is driven primarily by improving but still volatile fundamentals: strong free cash flow and healthy margins are offset by thin/unstable bottom-line results and weak returns. Technicals add near-term risk with a bearish trend despite oversold readings, while valuation (P/E ~29.9 with a low yield) provides limited support. The CEO change is a modest positive but not enough to outweigh the earnings stability and momentum concerns.

Positive Factors

Strong free cash flow

Consistent, multi-year free cash flow near $38M provides durable internal funding for capex, working capital and debt paydown. Strong FCF cushions the business against earnings swings, supports reinvestment in product lines and preserves strategic optionality over 2–6 months.

Negative Factors

Earnings volatility

Sharp swings from loss to near-breakeven undermine predictability of earnings and make budgeting and capital allocation harder. Volatile net income can limit consistent reinvestment or dividend policies and raises execution and forecasting risk for the next several quarters.

Mesa Laboratories Business Overview & Revenue Model

Company Description

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segme...

Read more

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segme...

How the Company Makes Money

Mesa Laboratories makes money primarily by selling products and solutions that support customers’ ongoing compliance, validation, and monitoring needs. Its revenue is generated through multiple product lines, including: (1) Sterilization and Disin...

Read more

Mesa Laboratories makes money primarily by selling products and solutions that support customers’ ongoing compliance, validation, and monitoring needs. Its revenue is generated through multiple product lines, including: (1) Sterilization and Disin...

Mesa Laboratories Financial Statement Overview

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	247.54M	240.98M	216.19M	219.08M	184.34M	133.94M
Gross Profit	150.03M	150.87M	133.25M	133.69M	109.09M	87.01M
EBITDA	44.33M	42.35M	-238.38M	37.52M	32.53M	27.99M
Net Income	3.73M	-1.97M	-254.25M	930.00K	1.87M	3.27M
Balance Sheet
Total Assets	434.85M	433.35M	446.80M	661.83M	707.37M	601.48M
Cash, Cash Equivalents and Short-Term Investments	28.98M	27.32M	28.21M	32.91M	49.35M	263.87M
Total Debt	103.41M	181.47M	231.30M	186.14M	221.13M	146.70M
Total Liabilities	248.16M	273.52M	301.40M	268.35M	313.57M	195.25M
Stockholders Equity	186.69M	159.83M	145.39M	393.48M	393.80M	406.23M
Cash Flow
Free Cash Flow	37.69M	42.31M	41.57M	23.44M	34.79M	35.08M
Operating Cash Flow	41.53M	46.81M	44.13M	27.98M	39.22M	37.07M
Investing Cash Flow	-3.84M	-4.50M	-81.31M	-9.49M	-305.23M	-1.99M
Financing Cash Flow	-42.29M	-44.51M	32.84M	-33.33M	52.58M	146.23M

Mesa Laboratories Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 92.83
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MLAB, the sentiment is Positive. The current price of 92.83 is above the 20-day moving average (MA) of 84.92, above the 50-day MA of 87.32, and above the 200-day MA of 78.62, indicating a bullish trend. The MACD of 2.01 indicates Negative momentum. The RSI at 60.75 is Neutral, neither overbought nor oversold. The STOCH value of 77.70 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MLAB.

Mesa Laboratories Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
LYTS	68 Neutral	$596.20M	22.22	10.90%	1.07%	22.35%	2.59%
DAKT	66 Neutral	$960.65M	93.63	9.64%	―	-6.13%	-76.92%
RELL	66 Neutral	$206.56M	42.82	0.51%	2.25%	6.17%	―
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
MLAB	58 Neutral	$512.87M	29.91	2.14%	0.79%	7.39%	99.34%
VPG	55 Neutral	$654.63M	96.46	1.59%	―	-7.46%	-39.98%
LPTH	53 Neutral	$701.74M	-13.49	-70.17%	―	36.85%	-77.93%

Mesa Laboratories Corporate Events